{"brief_title": "A Safety and Efficacy Study of Travoprost 0.004% Compared to Latanoprost 0.005% in Patients With Chronic Angle-Closure Glaucoma", "brief_summary": "To demonstrate that the intraocular pressure(IOP)-lowering efficacy of Travoprost (0.004%) is equal or better than that of Latanoprost 0.005% in patients with chronic angle-closure glaucoma.", "condition": ["Glaucoma, Angle-Closure", "Ocular Hypertension"], "intervention_type": ["Drug", "Drug"], "intervention_name": ["Travoprost (0.004%)", "Latanoprost (0.005%)"], "criteria": "Adult patients of any race and either sex with chronic angle-closure glaucoma.", "gender": "All", "minimum_age": "18 Years", "maximum_age": "N/A", "healthy_volunteers": "No", "keyword": "OHT", "mesh_term": ["Glaucoma", "Ocular Hypertension", "Glaucoma, Angle-Closure", "Latanoprost", "Travoprost"], "id": "NCT00051181"}